A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of ...
Some recent data suggest that, for now, COVID-19 may be a year-round problem, driven more by human behavior and immunity levels than weather patterns. Credit: Unsplash / Maxime The pandemic may no ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...
Recent analyst actions have put the spotlight on significant upgrades and downgrades. Among the upgrades, Broadcom ...
Shifting guidelines bred confusion and put the onus on individuals for deciding when to mask, test and stay home. 2022 was the year many people decided the coronavirus pandemic had ended. President ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Visit San Antonio's CEO is ...
National Police Commissioner Fannie Masemola made these comments in his opening remarks before the committee as he began the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback